Similar articles

• Experience with neoral cyclosporine through the oral route in liver transplantation.

  Bilbao I, Lazaro JL, Pou L, Charco R, Hildalgo E, Murio E, Margarit C. Bilbao I, et al. Transplant Proc. 1998 Jun;30(4):1432-4. doi: 10.1016/s0041-1345(98)00303-0. Transplant Proc. 1998. PMID: 9636580 Clinical Trial. No abstract available.
• Comparison of tacrolimus with microemulsion cyclosporine as primary immunosuppression in hepatitis C patients after liver transplantation.

  Zervos XA, Weppler D, Fragulidis GP, Torres MB, Nery JR, Khan MF, Pinna AD, Kato T, Miller J, Reddy KR, Tzakis AG. Zervos XA, et al. Transplantation. 1998 Apr 27;65(8):1044-6. doi: 10.1097/00007890-199804270-00006. Transplantation. 1998. PMID: 9583863 Clinical Trial.
• Mycophenolate mofetil in combination with tacrolimus versus Neoral after liver transplantation.

  Klupp J, Glanemann M, Bechstein WO, Platz KP, Langrehr JM, Keck H, Settmacher U, Radtke C, Neuhaus R, Neuhaus P. Klupp J, et al. Transplant Proc. 1999 Feb-Mar;31(1-2):1113-4. doi: 10.1016/s0041-1345(98)01925-3. Transplant Proc. 1999. PMID: 10083497 Clinical Trial. No abstract available.
• Neoral is superior to FK 506 in liver transplantation.

  Levy GA. Levy GA. Transplant Proc. 1998 Aug;30(5):1812-5. doi: 10.1016/s0041-1345(98)00442-4. Transplant Proc. 1998. PMID: 9723293 Review. No abstract available.
• Liver transplantation: changing goals in immunosuppression.

  McMaster P, Gunson B, Min X, Afonso R, Bastos J. McMaster P, et al. Transplant Proc. 1998 Aug;30(5):1819-21. doi: 10.1016/s0041-1345(98)00444-8. Transplant Proc. 1998. PMID: 9723295 Review. No abstract available.